Geoffrey M. Lynn
- Immunology top 10%
- Immunotherapy and Immune Responses 11
- Immune Cell Function and Interaction 4
-
- CAR-T cell therapy research 4
- Cancer Immunotherapy and Biomarkers 3
-
- Nanoparticle-Based Drug Delivery 2
-
- Virus-based gene therapy research 3
-
- RNA Interference and Gene Delivery 3
-
- Herpesvirus Infections and Treatments 2
- Co-authors
- Getahun MergaDan MeiselRobert L. WilsonBratoljub H. MilosavljevicAndrew S. IshizukaRobert A. SederFaezzah BaharomRamiro A. Ramirez-Valdez
- Cited by
- ImmunologyOncologyDrug Discovery
- Partner nations
- United StatesCzechiaUnited Kingdom
In The Last Decade
Geoffrey M. Lynn
18 papers receiving 765 citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Immunology 329
- Oncology 206
- Drug Discovery 1
- Biomaterials 60
- Cardiology and Cardiovascular Medicine 82
Countries citing papers authored by Geoffrey M. Lynn
This map shows the geographic impact of Geoffrey M. Lynn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffrey M. Lynn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffrey M. Lynn more than expected).
Fields of papers citing papers by Geoffrey M. Lynn
This network shows the impact of papers produced by Geoffrey M. Lynn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffrey M. Lynn. The network helps show where Geoffrey M. Lynn may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Geoffrey M. Lynn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 7 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 6 | |
| 5 | 2023 | 16 | |
| 6 | Systemic vaccination induces CD8+ T cells and remodels the tumor microenvironmentbreakdown → | 2022 | 142 |
| 7 | 2022 | 2 | |
| 8 | 2021 | 15 | |
| 9 | 2021 | 17 | |
| 10 | 2020 | 157 | |
| 11 | 2019 | 26 | |
| 12 | 2019 | 53 | |
| 13 | 2019 | 32 | |
| 14 | 2019 | 34 | |
| 15 | 2017 | 2 | |
| 16 | 2016 | 2 | |
| 17 | 2007 | 167 | |
| 18 | 1992 | 98 |
About Geoffrey M. Lynn
Geoffrey M. Lynn is a scholar working on Immunology, Oncology and Virology, having authored 18 papers that have together received 782 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (11 papers), CAR-T cell therapy research (4 papers), Immune Cell Function and Interaction (4 papers), Virus-based gene therapy research (3 papers), RNA Interference and Gene Delivery (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Nanoparticle-Based Drug Delivery (2 papers) and Herpesvirus Infections and Treatments (2 papers). The work is most often cited by research in Immunology (329 citations), Oncology (206 citations) and Drug Discovery (1 citation). Geoffrey M. Lynn has collaborated with scholars based in United States, Czechia and United Kingdom. Frequent co-authors include Getahun Merga, Dan Meisel, Robert L. Wilson, Bratoljub H. Milosavljevic, Andrew S. Ishizuka, Robert A. Seder, Faezzah Baharom, Ramiro A. Ramirez-Valdez, James Reed and Gary G. Nicholas. Their work appears in journals such as Cell, Nature Communications and Nature Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.